StreetInsider.com News Articles

WELL Health and HEALWELL AI Launch WELLTRUST to Empower Patients and Accelerate AI Powered Ethical Patient Identification for Clinical Research

Thu, 19 Feb 2026 07:00:00 -0500

WELL and HEALWELL launch WELLTRUST™, a consent-first data governance and patient-identification platform enabling secure, compliant and scalable clinics data mobilization across WELL-operated clinics.
WELLTRUST provides patients with clear, flexible, and revocable control over consent, while enabling researchers and clinicians to identify appropriate patients in an ethical, privacy-first way.
The first commercial application combines WELL’s expansive clinical footprint with HEALWELL’s DARWEN™ AI platform to identify and engage high-fit patients with chronic, rare, and complex conditions for clinical trials, improving recruitment at scale while preserving privacy.

VANCOUVER, British Columbia & TORONTO--(BUSINESS WIRE)-- WELL Health Technologies Corp. (TSX: WELL; OTCQX: WHTCF) (the

WELL Health and HEALWELL AI Launch WELLTRUST to Empower Patients and Accelerate AI Powered Ethical Patient Identification for Clinical Research

Thu, 19 Feb 2026 07:00:00 -0500

WELL and HEALWELL launch WELLTRUST™, a consent-first data governance and patient-identification platform enabling secure, compliant and scalable clinics data mobilization across WELL-operated clinics.
WELLTRUST provides patients with clear, flexible, and revocable control over consent, while enabling researchers and clinicians to identify appropriate patients in an ethical, privacy-first way.
The first commercial application combines WELL’s expansive clinical footprint with HEALWELL’s DARWEN™ AI platform to identify and engage high-fit patients with chronic, rare, and complex conditions for clinical trials, improving recruitment at scale while preserving privacy.

VANCOUVER, British Columbia & TORONTO--(BUSINESS WIRE)-- WELL Health Technologies Corp. (TSX: WELL; OTCQX: WHTCF) (the

WELL Health and HEALWELL AI Launch WELLTRUST to Empower Patients and Accelerate AI Powered Ethical Patient Identification for Clinical Research

Thu, 19 Feb 2026 07:00:00 -0500

WELL and HEALWELL launch WELLTRUST™, a consent-first data governance and patient-identification platform enabling secure, compliant and scalable clinics data mobilization across WELL-operated clinics.
WELLTRUST provides patients with clear, flexible, and revocable control over consent, while enabling researchers and clinicians to identify appropriate patients in an ethical, privacy-first way.
The first commercial application combines WELL’s expansive clinical footprint with HEALWELL’s DARWEN™ AI platform to identify and engage high-fit patients with chronic, rare, and complex conditions for clinical trials, improving recruitment at scale while preserving privacy.

VANCOUVER, British Columbia & TORONTO--(BUSINESS WIRE)-- WELL Health Technologies Corp. (TSX: WELL; OTCQX: WHTCF) (the

WELL Health and HEALWELL AI Launch WELLTRUST to Empower Patients and Accelerate AI Powered Ethical Patient Identification for Clinical Research

Thu, 19 Feb 2026 07:00:00 -0500

WELL and HEALWELL launch WELLTRUST™, a consent-first data governance and patient-identification platform enabling secure, compliant and scalable clinics data mobilization across WELL-operated clinics.
WELLTRUST provides patients with clear, flexible, and revocable control over consent, while enabling researchers and clinicians to identify appropriate patients in an ethical, privacy-first way.
The first commercial application combines WELL’s expansive clinical footprint with HEALWELL’s DARWEN™ AI platform to identify and engage high-fit patients with chronic, rare, and complex conditions for clinical trials, improving recruitment at scale while preserving privacy.

VANCOUVER, British Columbia & TORONTO--(BUSINESS WIRE)-- WELL Health Technologies Corp. (TSX: WELL; OTCQX: WHTCF) (the

WELL Health and HEALWELL AI Launch WELLTRUST to Empower Patients and Accelerate AI Powered Ethical Patient Identification for Clinical Research

Thu, 19 Feb 2026 07:00:00 -0500

WELL and HEALWELL launch WELLTRUST™, a consent-first data governance and patient-identification platform enabling secure, compliant and scalable clinics data mobilization across WELL-operated clinics.
WELLTRUST provides patients with clear, flexible, and revocable control over consent, while enabling researchers and clinicians to identify appropriate patients in an ethical, privacy-first way.
The first commercial application combines WELL’s expansive clinical footprint with HEALWELL’s DARWEN™ AI platform to identify and engage high-fit patients with chronic, rare, and complex conditions for clinical trials, improving recruitment at scale while preserving privacy.

VANCOUVER, British Columbia & TORONTO--(BUSINESS WIRE)-- WELL Health Technologies Corp. (TSX: WELL; OTCQX: WHTCF) (the

WELL Health and HEALWELL AI Launch WELLTRUST to Empower Patients and Accelerate AI Powered Ethical Patient Identification for Clinical Research

Thu, 19 Feb 2026 07:00:00 -0500

WELL and HEALWELL launch WELLTRUST™, a consent-first data governance and patient-identification platform enabling secure, compliant and scalable clinics data mobilization across WELL-operated clinics.
WELLTRUST provides patients with clear, flexible, and revocable control over consent, while enabling researchers and clinicians to identify appropriate patients in an ethical, privacy-first way.
The first commercial application combines WELL’s expansive clinical footprint with HEALWELL’s DARWEN™ AI platform to identify and engage high-fit patients with chronic, rare, and complex conditions for clinical trials, improving recruitment at scale while preserving privacy.

VANCOUVER, British Columbia & TORONTO--(BUSINESS WIRE)-- WELL Health Technologies Corp. (TSX: WELL; OTCQX: WHTCF) (the

WELL Health and HEALWELL AI Launch WELLTRUST to Empower Patients and Accelerate AI Powered Ethical Patient Identification for Clinical Research

Thu, 19 Feb 2026 07:00:00 -0500

WELL and HEALWELL launch WELLTRUST™, a consent-first data governance and patient-identification platform enabling secure, compliant and scalable clinics data mobilization across WELL-operated clinics.
WELLTRUST provides patients with clear, flexible, and revocable control over consent, while enabling researchers and clinicians to identify appropriate patients in an ethical, privacy-first way.
The first commercial application combines WELL’s expansive clinical footprint with HEALWELL’s DARWEN™ AI platform to identify and engage high-fit patients with chronic, rare, and complex conditions for clinical trials, improving recruitment at scale while preserving privacy.

VANCOUVER, British Columbia & TORONTO--(BUSINESS WIRE)-- WELL Health Technologies Corp. (TSX: WELL; OTCQX: WHTCF) (the

WELL Health and HEALWELL AI Launch WELLTRUST to Empower Patients and Accelerate AI Powered Ethical Patient Identification for Clinical Research

Thu, 19 Feb 2026 07:00:00 -0500

WELL and HEALWELL launch WELLTRUST™, a consent-first data governance and patient-identification platform enabling secure, compliant and scalable clinics data mobilization across WELL-operated clinics.
WELLTRUST provides patients with clear, flexible, and revocable control over consent, while enabling researchers and clinicians to identify appropriate patients in an ethical, privacy-first way.
The first commercial application combines WELL’s expansive clinical footprint with HEALWELL’s DARWEN™ AI platform to identify and engage high-fit patients with chronic, rare, and complex conditions for clinical trials, improving recruitment at scale while preserving privacy.

VANCOUVER, British Columbia & TORONTO--(BUSINESS WIRE)-- WELL Health Technologies Corp. (TSX: WELL; OTCQX: WHTCF) (the

WELL Health and HEALWELL AI Launch WELLTRUST to Empower Patients and Accelerate AI Powered Ethical Patient Identification for Clinical Research

Thu, 19 Feb 2026 07:00:00 -0500

WELL and HEALWELL launch WELLTRUST™, a consent-first data governance and patient-identification platform enabling secure, compliant and scalable clinics data mobilization across WELL-operated clinics.
WELLTRUST provides patients with clear, flexible, and revocable control over consent, while enabling researchers and clinicians to identify appropriate patients in an ethical, privacy-first way.
The first commercial application combines WELL’s expansive clinical footprint with HEALWELL’s DARWEN™ AI platform to identify and engage high-fit patients with chronic, rare, and complex conditions for clinical trials, improving recruitment at scale while preserving privacy.

VANCOUVER, British Columbia & TORONTO--(BUSINESS WIRE)-- WELL Health Technologies Corp. (TSX: WELL; OTCQX: WHTCF) (the

WELL Health and HEALWELL AI Launch WELLTRUST to Empower Patients and Accelerate AI Powered Ethical Patient Identification for Clinical Research

Thu, 19 Feb 2026 07:00:00 -0500

WELL and HEALWELL launch WELLTRUST™, a consent-first data governance and patient-identification platform enabling secure, compliant and scalable clinics data mobilization across WELL-operated clinics.
WELLTRUST provides patients with clear, flexible, and revocable control over consent, while enabling researchers and clinicians to identify appropriate patients in an ethical, privacy-first way.
The first commercial application combines WELL’s expansive clinical footprint with HEALWELL’s DARWEN™ AI platform to identify and engage high-fit patients with chronic, rare, and complex conditions for clinical trials, improving recruitment at scale while preserving privacy.

VANCOUVER, British Columbia & TORONTO--(BUSINESS WIRE)-- WELL Health Technologies Corp. (TSX: WELL; OTCQX: WHTCF) (the

WELL Health and HEALWELL AI Launch WELLTRUST to Empower Patients and Accelerate AI Powered Ethical Patient Identification for Clinical Research

Thu, 19 Feb 2026 07:00:00 -0500

WELL and HEALWELL launch WELLTRUST™, a consent-first data governance and patient-identification platform enabling secure, compliant and scalable clinics data mobilization across WELL-operated clinics.
WELLTRUST provides patients with clear, flexible, and revocable control over consent, while enabling researchers and clinicians to identify appropriate patients in an ethical, privacy-first way.
The first commercial application combines WELL’s expansive clinical footprint with HEALWELL’s DARWEN™ AI platform to identify and engage high-fit patients with chronic, rare, and complex conditions for clinical trials, improving recruitment at scale while preserving privacy.

VANCOUVER, British Columbia & TORONTO--(BUSINESS WIRE)-- WELL Health Technologies Corp. (TSX: WELL; OTCQX: WHTCF) (the

WELL Health and HEALWELL AI Launch WELLTRUST to Empower Patients and Accelerate AI Powered Ethical Patient Identification for Clinical Research

Thu, 19 Feb 2026 07:00:00 -0500

WELL and HEALWELL launch WELLTRUST™, a consent-first data governance and patient-identification platform enabling secure, compliant and scalable clinics data mobilization across WELL-operated clinics.
WELLTRUST provides patients with clear, flexible, and revocable control over consent, while enabling researchers and clinicians to identify appropriate patients in an ethical, privacy-first way.
The first commercial application combines WELL’s expansive clinical footprint with HEALWELL’s DARWEN™ AI platform to identify and engage high-fit patients with chronic, rare, and complex conditions for clinical trials, improving recruitment at scale while preserving privacy.

VANCOUVER, British Columbia & TORONTO--(BUSINESS WIRE)-- WELL Health Technologies Corp. (TSX: WELL; OTCQX: WHTCF) (the

WELL Health and HEALWELL AI Launch WELLTRUST to Empower Patients and Accelerate AI Powered Ethical Patient Identification for Clinical Research

Thu, 19 Feb 2026 07:00:00 -0500

WELL and HEALWELL launch WELLTRUST™, a consent-first data governance and patient-identification platform enabling secure, compliant and scalable clinics data mobilization across WELL-operated clinics.
WELLTRUST provides patients with clear, flexible, and revocable control over consent, while enabling researchers and clinicians to identify appropriate patients in an ethical, privacy-first way.
The first commercial application combines WELL’s expansive clinical footprint with HEALWELL’s DARWEN™ AI platform to identify and engage high-fit patients with chronic, rare, and complex conditions for clinical trials, improving recruitment at scale while preserving privacy.

VANCOUVER, British Columbia & TORONTO--(BUSINESS WIRE)-- WELL Health Technologies Corp. (TSX: WELL; OTCQX: WHTCF) (the

WELL Health and HEALWELL AI Launch WELLTRUST to Empower Patients and Accelerate AI Powered Ethical Patient Identification for Clinical Research

Thu, 19 Feb 2026 07:00:00 -0500

WELL and HEALWELL launch WELLTRUST™, a consent-first data governance and patient-identification platform enabling secure, compliant and scalable clinics data mobilization across WELL-operated clinics.
WELLTRUST provides patients with clear, flexible, and revocable control over consent, while enabling researchers and clinicians to identify appropriate patients in an ethical, privacy-first way.
The first commercial application combines WELL’s expansive clinical footprint with HEALWELL’s DARWEN™ AI platform to identify and engage high-fit patients with chronic, rare, and complex conditions for clinical trials, improving recruitment at scale while preserving privacy.

VANCOUVER, British Columbia & TORONTO--(BUSINESS WIRE)-- WELL Health Technologies Corp. (TSX: WELL; OTCQX: WHTCF) (the

WELL Health and HEALWELL AI Launch WELLTRUST to Empower Patients and Accelerate AI Powered Ethical Patient Identification for Clinical Research

Thu, 19 Feb 2026 07:00:00 -0500

WELL and HEALWELL launch WELLTRUST™, a consent-first data governance and patient-identification platform enabling secure, compliant and scalable clinics data mobilization across WELL-operated clinics.
WELLTRUST provides patients with clear, flexible, and revocable control over consent, while enabling researchers and clinicians to identify appropriate patients in an ethical, privacy-first way.
The first commercial application combines WELL’s expansive clinical footprint with HEALWELL’s DARWEN™ AI platform to identify and engage high-fit patients with chronic, rare, and complex conditions for clinical trials, improving recruitment at scale while preserving privacy.

VANCOUVER, British Columbia & TORONTO--(BUSINESS WIRE)-- WELL Health Technologies Corp. (TSX: WELL; OTCQX: WHTCF) (the

WELL Health and HEALWELL AI Launch WELLTRUST to Empower Patients and Accelerate AI Powered Ethical Patient Identification for Clinical Research

Thu, 19 Feb 2026 07:00:00 -0500

WELL and HEALWELL launch WELLTRUST™, a consent-first data governance and patient-identification platform enabling secure, compliant and scalable clinics data mobilization across WELL-operated clinics.
WELLTRUST provides patients with clear, flexible, and revocable control over consent, while enabling researchers and clinicians to identify appropriate patients in an ethical, privacy-first way.
The first commercial application combines WELL’s expansive clinical footprint with HEALWELL’s DARWEN™ AI platform to identify and engage high-fit patients with chronic, rare, and complex conditions for clinical trials, improving recruitment at scale while preserving privacy.

VANCOUVER, British Columbia & TORONTO--(BUSINESS WIRE)-- WELL Health Technologies Corp. (TSX: WELL; OTCQX: WHTCF) (the

WELL Health Reports HEALWELL AI and WELLSTAR Subsidiaries Are Selected for Canada Health Infoway’s Vendor Innovation Program

Wed, 28 May 2025 07:01:00 -0500

WELL Health is pleased to report that HEALWELL’s wholly owned subsidiary Intrahealth, non-wholly owned subsidiary Pentavere along with WELLSTAR’s subsidiary OceanMD have been selected by Canada Health Infoway as recipients for the 2025 Vendor Innovation Program. The Vendor Innovation Program is designed to accelerate the development, clinical implementation and adoption of interoperability in healthcare settings across Canada.
Intrahealth, Pentavere and OceanMD are engaging in projects that accelerate the adoption of interoperability by improving data quality, enhancing care coordination, and expanding access to standardized, actionable health information for patients and clinicians across Canada. Their projects were selected not only based on

WELL Health Reports HEALWELL AI and WELLSTAR Subsidiaries Are Selected for Canada Health Infoway’s Vendor Innovation Program

Wed, 28 May 2025 07:01:00 -0500

WELL Health is pleased to report that HEALWELL’s wholly owned subsidiary Intrahealth, non-wholly owned subsidiary Pentavere along with WELLSTAR’s subsidiary OceanMD have been selected by Canada Health Infoway as recipients for the 2025 Vendor Innovation Program. The Vendor Innovation Program is designed to accelerate the development, clinical implementation and adoption of interoperability in healthcare settings across Canada.
Intrahealth, Pentavere and OceanMD are engaging in projects that accelerate the adoption of interoperability by improving data quality, enhancing care coordination, and expanding access to standardized, actionable health information for patients and clinicians across Canada. Their projects were selected not only based on

WELL Health Reports HEALWELL AI and WELLSTAR Subsidiaries Are Selected for Canada Health Infoway’s Vendor Innovation Program

Wed, 28 May 2025 07:01:00 -0500

WELL Health is pleased to report that HEALWELL’s wholly owned subsidiary Intrahealth, non-wholly owned subsidiary Pentavere along with WELLSTAR’s subsidiary OceanMD have been selected by Canada Health Infoway as recipients for the 2025 Vendor Innovation Program. The Vendor Innovation Program is designed to accelerate the development, clinical implementation and adoption of interoperability in healthcare settings across Canada.
Intrahealth, Pentavere and OceanMD are engaging in projects that accelerate the adoption of interoperability by improving data quality, enhancing care coordination, and expanding access to standardized, actionable health information for patients and clinicians across Canada. Their projects were selected not only based on

WELL Health Reports HEALWELL AI and WELLSTAR Subsidiaries Are Selected for Canada Health Infoway’s Vendor Innovation Program

Wed, 28 May 2025 07:01:00 -0500

WELL Health is pleased to report that HEALWELL’s wholly owned subsidiary Intrahealth, non-wholly owned subsidiary Pentavere along with WELLSTAR’s subsidiary OceanMD have been selected by Canada Health Infoway as recipients for the 2025 Vendor Innovation Program. The Vendor Innovation Program is designed to accelerate the development, clinical implementation and adoption of interoperability in healthcare settings across Canada.
Intrahealth, Pentavere and OceanMD are engaging in projects that accelerate the adoption of interoperability by improving data quality, enhancing care coordination, and expanding access to standardized, actionable health information for patients and clinicians across Canada. Their projects were selected not only based on

WELL Health Reports HEALWELL AI and WELLSTAR Subsidiaries Are Selected for Canada Health Infoway’s Vendor Innovation Program

Wed, 28 May 2025 07:01:00 -0500

WELL Health is pleased to report that HEALWELL’s wholly owned subsidiary Intrahealth, non-wholly owned subsidiary Pentavere along with WELLSTAR’s subsidiary OceanMD have been selected by Canada Health Infoway as recipients for the 2025 Vendor Innovation Program. The Vendor Innovation Program is designed to accelerate the development, clinical implementation and adoption of interoperability in healthcare settings across Canada.
Intrahealth, Pentavere and OceanMD are engaging in projects that accelerate the adoption of interoperability by improving data quality, enhancing care coordination, and expanding access to standardized, actionable health information for patients and clinicians across Canada. Their projects were selected not only based on

WELL Health Reports HEALWELL AI and WELLSTAR Subsidiaries Are Selected for Canada Health Infoway’s Vendor Innovation Program

Wed, 28 May 2025 07:01:00 -0500

WELL Health is pleased to report that HEALWELL’s wholly owned subsidiary Intrahealth, non-wholly owned subsidiary Pentavere along with WELLSTAR’s subsidiary OceanMD have been selected by Canada Health Infoway as recipients for the 2025 Vendor Innovation Program. The Vendor Innovation Program is designed to accelerate the development, clinical implementation and adoption of interoperability in healthcare settings across Canada.
Intrahealth, Pentavere and OceanMD are engaging in projects that accelerate the adoption of interoperability by improving data quality, enhancing care coordination, and expanding access to standardized, actionable health information for patients and clinicians across Canada. Their projects were selected not only based on

WELL Health Reports HEALWELL AI and WELLSTAR Subsidiaries Are Selected for Canada Health Infoway’s Vendor Innovation Program

Wed, 28 May 2025 07:01:00 -0500

WELL Health is pleased to report that HEALWELL’s wholly owned subsidiary Intrahealth, non-wholly owned subsidiary Pentavere along with WELLSTAR’s subsidiary OceanMD have been selected by Canada Health Infoway as recipients for the 2025 Vendor Innovation Program. The Vendor Innovation Program is designed to accelerate the development, clinical implementation and adoption of interoperability in healthcare settings across Canada.
Intrahealth, Pentavere and OceanMD are engaging in projects that accelerate the adoption of interoperability by improving data quality, enhancing care coordination, and expanding access to standardized, actionable health information for patients and clinicians across Canada. Their projects were selected not only based on

WELL Health Reports HEALWELL AI and WELLSTAR Subsidiaries Are Selected for Canada Health Infoway’s Vendor Innovation Program

Wed, 28 May 2025 07:01:00 -0500

WELL Health is pleased to report that HEALWELL’s wholly owned subsidiary Intrahealth, non-wholly owned subsidiary Pentavere along with WELLSTAR’s subsidiary OceanMD have been selected by Canada Health Infoway as recipients for the 2025 Vendor Innovation Program. The Vendor Innovation Program is designed to accelerate the development, clinical implementation and adoption of interoperability in healthcare settings across Canada.
Intrahealth, Pentavere and OceanMD are engaging in projects that accelerate the adoption of interoperability by improving data quality, enhancing care coordination, and expanding access to standardized, actionable health information for patients and clinicians across Canada. Their projects were selected not only based on

WELL Health Reports HEALWELL AI and WELLSTAR Subsidiaries Are Selected for Canada Health Infoway’s Vendor Innovation Program

Wed, 28 May 2025 07:01:00 -0500

WELL Health is pleased to report that HEALWELL’s wholly owned subsidiary Intrahealth, non-wholly owned subsidiary Pentavere along with WELLSTAR’s subsidiary OceanMD have been selected by Canada Health Infoway as recipients for the 2025 Vendor Innovation Program. The Vendor Innovation Program is designed to accelerate the development, clinical implementation and adoption of interoperability in healthcare settings across Canada.
Intrahealth, Pentavere and OceanMD are engaging in projects that accelerate the adoption of interoperability by improving data quality, enhancing care coordination, and expanding access to standardized, actionable health information for patients and clinicians across Canada. Their projects were selected not only based on